TW200509921A - Alkaline salts - Google Patents

Alkaline salts

Info

Publication number: TW200509921A
Authority: TW; Taiwan
Prior art keywords: alkaline salts; alkaline; salts; medicaments; compounds
Prior art date: 2003-07-23

Application number

TW093122166A

Other languages

English (en)

Inventor

Bernhard Kohl

Bernd Muller

Ernst Sturm

Rolf-Peter Hummel

Original Assignee

Altana Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-23

Filing date

2004-07-23

Publication date

2005-03-16

2004-07-23 Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag

2005-03-16 Publication of TW200509921A publication Critical patent/TW200509921A/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

TW093122166A 2003-07-23 2004-07-23 Alkaline salts TW200509921A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03016759		2003-07-23
EP03016760		2003-07-23

Publications (1)

Publication Number	Publication Date
TW200509921A true TW200509921A (en)	2005-03-16

Family

ID=34117526

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW093122166A TW200509921A (en)	2003-07-23	2004-07-23	Alkaline salts

Country Status (18)

Country	Link
US (1)	US20060189590A1 (zh)
EP (1)	EP1651217B1 (zh)
JP (1)	JP2006528158A (zh)
AR (1)	AR046400A1 (zh)
AT (1)	ATE386522T1 (zh)
AU (1)	AU2004260832A1 (zh)
CA (1)	CA2532774A1 (zh)
DE (1)	DE602004011946T2 (zh)
DK (1)	DK1651217T3 (zh)
ES (1)	ES2302007T3 (zh)
HR (1)	HRP20080191T3 (zh)
IL (1)	IL172600A0 (zh)
MX (1)	MXPA06000652A (zh)
PL (1)	PL1651217T3 (zh)
PT (1)	PT1651217E (zh)
SI (1)	SI1651217T1 (zh)
TW (1)	TW200509921A (zh)
WO (1)	WO2005011692A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1572680A2 (en)	2002-12-19	2005-09-14	Eva Pharmaceutical Industries Ltd.	Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation.
TWI372066B (en) *	2003-10-01	2012-09-11	Wyeth Corp	Pantoprazole multiparticulate formulations
WO2007041790A1 (en) *	2005-10-14	2007-04-19	Jon Pty Limited	Salts of proton pump inhibitors and process for preparing same
AU2006306906B2 (en) *	2005-10-26	2010-02-04	Hanmi Science Co., Ltd.	S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
US7576219B2 (en) *	2005-10-26	2009-08-18	Hanmi Pharm. Co., Ltd	Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
US8512761B2 (en)	2006-01-27	2013-08-20	Yale University	Fast acting inhibitor of gastric acid secretion
CN101374526B (zh)	2006-01-27	2013-08-07	耶鲁大学	胃酸分泌的快速作用抑制剂
WO2009155130A1 (en)	2008-06-19	2009-12-23	Marvell World Trade Ltd.	Split edge enhancement architecture
CN102336788B (zh) *	2011-06-29	2014-08-27	涂家生	质子泵抑制剂氨基葡萄糖复盐

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8301182D0 (sv) *	1983-03-04	1983-03-04	Haessle Ab	Novel compounds
CA2161130A1 (en) *	1993-04-27	1994-11-10	Nancy M. Gray	Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
SE9301830D0 (sv) *	1993-05-28	1993-05-28	Ab Astra	New compounds
SE510650C2 (sv) *	1997-05-30	1999-06-14	Astra Ab	Ny förening
DE19843413C1 (de) *	1998-08-18	2000-03-30	Byk Gulden Lomberg Chem Fab	Neue Salzform von Pantoprazol
DE10061137B4 (de) *	2000-12-07	2016-10-06	Takeda Gmbh	Neue pharmazeutische Zubereitung

2004
- 2004-07-22 AR ARP040102594A patent/AR046400A1/es not_active Application Discontinuation
- 2004-07-22 PT PT04742008T patent/PT1651217E/pt unknown
- 2004-07-22 DK DK04742008T patent/DK1651217T3/da active
- 2004-07-22 PL PL04742008T patent/PL1651217T3/pl unknown
- 2004-07-22 EP EP04742008A patent/EP1651217B1/en not_active Expired - Lifetime
- 2004-07-22 AU AU2004260832A patent/AU2004260832A1/en not_active Abandoned
- 2004-07-22 ES ES04742008T patent/ES2302007T3/es not_active Expired - Lifetime
- 2004-07-22 CA CA002532774A patent/CA2532774A1/en not_active Abandoned
- 2004-07-22 SI SI200430707T patent/SI1651217T1/sl unknown
- 2004-07-22 DE DE602004011946T patent/DE602004011946T2/de not_active Expired - Fee Related
- 2004-07-22 JP JP2006520838A patent/JP2006528158A/ja not_active Withdrawn
- 2004-07-22 WO PCT/EP2004/051578 patent/WO2005011692A1/en active IP Right Grant
- 2004-07-22 MX MXPA06000652A patent/MXPA06000652A/es active IP Right Grant
- 2004-07-22 US US10/564,768 patent/US20060189590A1/en not_active Abandoned
- 2004-07-22 AT AT04742008T patent/ATE386522T1/de not_active IP Right Cessation
- 2004-07-23 TW TW093122166A patent/TW200509921A/zh unknown
2005
- 2005-12-15 IL IL172600A patent/IL172600A0/en unknown
2008
- 2008-04-28 HR HR20080191T patent/HRP20080191T3/xx unknown

Also Published As

Publication number	Publication date
PL1651217T3 (pl)	2008-07-31
EP1651217A1 (en)	2006-05-03
CA2532774A1 (en)	2005-02-10
HRP20080191T3 (en)	2008-05-31
DE602004011946T2 (de)	2009-03-19
AR046400A1 (es)	2005-12-07
DK1651217T3 (da)	2008-06-16
JP2006528158A (ja)	2006-12-14
SI1651217T1 (sl)	2008-08-31
IL172600A0 (en)	2006-04-10
ATE386522T1 (de)	2008-03-15
PT1651217E (pt)	2008-05-23
DE602004011946D1 (de)	2008-04-03
US20060189590A1 (en)	2006-08-24
AU2004260832A1 (en)	2005-02-10
EP1651217B1 (en)	2008-02-20
WO2005011692A1 (en)	2005-02-10
ES2302007T3 (es)	2008-07-01
MXPA06000652A (es)	2006-03-30

Publication	Publication Date	Title
PL372926A1 (en)	2005-08-08	Piperidine-pyridazones and phthalazones as pde4 inhibitors
HK1080470A1 (en)	2006-04-28	Heterocyclic compounds
DE60334536D1 (de)	2010-11-25	Furylverbindungen
MXPA05012463A (es)	2006-01-30	Combinaciones farmaceuticas de un inhibidor de bomba protonica y un compuesto que modifica la motilidad gastrointestinal.
HK1079522A1 (en)	2006-04-07	Thienyl compounds
EP1534278A4 (en)	2006-09-06	NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
NO20053042L (no)	2005-06-21	Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
AP2002002466A0 (en)	2002-06-30	3-heterocycliylpropanohydroxamic acid PCP INHIBITORS.
TW200600499A (en)	2006-01-01	Novel amido-substituted hydroxy-6-phenylphenanthridines
TW200509921A (en)	2005-03-16	Alkaline salts
UA85505C2 (en)	2009-01-26	Kinase inhibitors
NO20080839L (no)	2008-02-18	Isotopsubstituerte protonpumpeinhibitorer
TW200720273A (en)	2007-06-01	Pharmaceutically active spiro-benzimidazoles
DK1244643T3 (da)	2004-10-18	Tryptaseinhibitorer
DK1244614T3 (da)	2004-09-27	Tryptase-inhibitorer
RS95304A (en)	2006-12-15	New combination fortreating airway disorders
MY137953A (en)	2009-04-30	New association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
DE60216920D1 (en)	2007-02-01	Tryptase-inhibitoren
NO20070058L (no)	2007-01-05	Amino-halogen-imidazopyridiner som protonpumpeinhibitorer
RS95204A (en)	2006-12-15	Combination for the treatment of airway disorders
DE60220504D1 (en)	2007-07-19	Tryptasehemmer
GB0205327D0 (en)	2002-04-17	compounds
WO2003075926A8 (en)	2003-12-24	Use of proton pump inhibitors for the treatment of airway disorders
TW200603801A (en)	2006-02-01	Novel dialkoxy-imidazopyridines
TW200505868A (en)	2005-02-16	New synerglstic combinations